Management of Pelvic Inflammatory Disease in Clinical Practice

References

• CDC. Pelvic Inflammatory Disease (PID) - STI treatment guidelines; 2022. Available from: https://www.cdc.gov/std/treatment-guidelines/pid.htm. Accessed February 28, 2022.
   Google Scholar
• Kreisel K, Torrone E, Bernstein K, Hong J, Gorwitz R. Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age — United States, 2013–2014. MMWR Morb Mortal Wkly Rep. 2017;66:80–83. doi:10.15585/mmwr.mm6603a3
   PubMed Web of Science ®Google Scholar
• Yusuf H, Trent M. Pelvic Inflammatory Disease in Adolescents. In: Reference Module in Biomedical Sciences. Elsevier; 2020.
   Google Scholar
• Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013;27:4. doi:10.1016/j.idc.2013.08.004
   Web of Science ®Google Scholar
• Trent M. Pelvic inflammatory disease. Pediatr Rev. 2013;34(4):163–172. doi:10.1542/pir.34.4.163
   PubMedGoogle Scholar
• Haggerty CL, Ness RB. Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther. 2006;4(2):235–247. doi:10.1586/14787210.4.2.235
   PubMedGoogle Scholar
• Anyalechi GE, Hong J, Kreisel K, et al. Self-reported infertility and associated pelvic inflammatory disease among women of reproductive age — national health and nutrition examination survey, United States, 2013–2016. Sex Transm Dis. 2019;46(7):446–451. doi:10.1097/OLQ.0000000000000996
   PubMed Web of Science ®Google Scholar
• Smith J, Daley FC, Shakur A, Addley HC, Moyle PL, Freeman S. Causes and complications of female pelvic inflammatory disease: a multimodal imaging review. ECR; 2018.
   Google Scholar
• Price MJ, Ades AE, Welton NJ, Simms I, Macleod J, Horner PJ. Proportion of pelvic inflammatory disease cases caused by chlamydia trachomatis: consistent picture from different methods. J Infect Dis. 2016;214(4):617–624. doi:10.1093/infdis/jiw178
   PubMed Web of Science ®Google Scholar
• Chen PC, Li PC, Ding DC. Pelvic inflammatory disease and causative pathogens in older women in a medical center in eastern Taiwan: a retrospective cross-sectional study. PLoS One. 2021;16(9):e0257627. doi:10.1371/journal.pone.0257627
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Zhang Q, Chen H, Feng Y. Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. J Med Microbiol. 2018;67(10):1519–1526. doi:10.1099/jmm.0.000821
   PubMed Web of Science ®Google Scholar
• Sethi S, Singh G, Samanta P, Sharma M. Mycoplasma genitalium: an emerging sexually transmitted pathogen. Indian J Med Res. 2012;136(6):942–955.
   PubMedGoogle Scholar
• Hughes G, Saunders J. Mycoplasma genitalium: the next sexually transmitted superbug? BMJ. 2018;363. doi:10.1136/bmj.k4376
   PubMedGoogle Scholar
• Vazquez F, Fernández J. Pelvic inflammatory disease due to mycoplasma genitalium: a character in search of an author. Clin Infect Dis. 2020;71(10):2723–2725. doi:10.1093/cid/ciaa506
   PubMed Web of Science ®Google Scholar
• Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol. 2012;206(6):476.e1–8. doi:10.1016/j.ajog.2012.02.036
   PubMed Web of Science ®Google Scholar
• Short VL, Totten PA, Ness RB, Astete SG, Kelsey SF, Haggerty CL. Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis. 2009;48(1):41–47. doi:10.1086/594123
   PubMed Web of Science ®Google Scholar
• Trent M, Yusuf HE, Perin J, et al. Clearance of mycoplasma genitalium and trichomonas vaginalis among adolescents and young adults with pelvic inflammatory disease: results from the tech-N study. Sex Transm Dis. 2020;47(11):e47–e50. doi:10.1097/OLQ.0000000000001221
   PubMedGoogle Scholar
• Baumann L, Cina M, Egli-Gany D, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect. 2018;94(4):255–262. doi:10.1136/sextrans-2017-053384
   PubMed Web of Science ®Google Scholar
• Seña AC, Lee JY, Schwebke J, et al. A silent epidemic: the prevalence, incidence and persistence of mycoplasma genitalium among young, asymptomatic high-risk women in the United States. Clin Infect Dis. 2018;67(1):73–79. doi:10.1093/cid/ciy025
   PubMed Web of Science ®Google Scholar
• Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985–2001. Sex Transm Dis. 2005;32(12):778–784. doi:10.1097/01.olq.0000175375.60973.cb
   PubMed Web of Science ®Google Scholar
• Yeh JM, Hook EW, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis. 2003;30(5):369–378. doi:10.1097/00007435-200305000-00001
   PubMed Web of Science ®Google Scholar
• Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial. Am J Obstet Gynecol. 2002;186(5):929–937. doi:10.1067/mob.2002.121625
   PubMed Web of Science ®Google Scholar
• Curry A, Williams T, Penny ML. Pelvic inflammatory disease: diagnosis, management, and prevention. Am Fam Physician. 2019;100(6):357–364.
   PubMed Web of Science ®Google Scholar
• Brun JL, Castan B, de Barbeyrac B, et al. Pelvic inflammatory diseases: updated French guidelines. J Gynecol Obstet Hum Reprod. 2020;49:101714. doi:10.1016/j.jogoh.2020.101714
   PubMed Web of Science ®Google Scholar
• Gradison M. Pelvic Inflammatory Disease. AFP. 2012;85(8):791–796.
   Google Scholar
• De Muylder X. Pelvic inflammatory disease in Zimbabwe. Guidelines for diagnosis and treatment. Trop Doct. 1988;18(2):84–88. doi:10.1177/004947558801800215
   PubMedGoogle Scholar
• Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108–114. doi:10.1177/0956462417744099
   PubMed Web of Science ®Google Scholar
• Qian S, Foster R, Bourne C, et al. Neisseria gonorrhoeae positivity in clients presenting as asymptomatic contacts of gonorrhoea at a sexual health centre. Sex Health. 2020;17(2):187–191. doi:10.1071/SH19091
   PubMed Web of Science ®Google Scholar
• Llata E, Bernstein KT, Kerani RP, et al. Management of pelvic inflammatory disease in selected U.S. Sexually transmitted disease clinics: sexually transmitted disease surveillance network, January 2010–December 2011. Sex Transm Dis. 2015;42(8):429–433. doi:10.1097/OLQ.0000000000000309
   PubMed Web of Science ®Google Scholar
• Hessol NA, Priddy FH, Bolan G, et al. Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis. 1996;23(2):157–163. doi:10.1097/00007435-199603000-00012
   PubMed Web of Science ®Google Scholar
• Goyal M, Hersh A, Luan X, Localio R, Trent M, Zaoutis T. Are emergency departments appropriately treating adolescent pelvic inflammatory disease? JAMA Pediatr. 2013;167(7):672. doi:10.1001/jamapediatrics.2013.1042
   PubMed Web of Science ®Google Scholar
• Health.gov. Women - healthy people 2030. Available from: https://health.gov/healthypeople/objectives-and-data/browse-objectives/women. Accessed June 6, 2022.
   Google Scholar
• Bosu WK, Annan JJ, Mabey D. The management of pelvic inflammatory disease in the central region of Ghana is not standardized. Int J STD AIDS. 1998;9(7):408–413. doi:10.1258/0956462981922502
   PubMed Web of Science ®Google Scholar
• Wiesenfeld HC, Manhart LE. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen. J Infect Dis. 2017;216(suppl_2):S389–S395. doi:10.1093/infdis/jix198
   PubMed Web of Science ®Google Scholar
• Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis. 2008;21(1):65–69. doi:10.1097/QCO.0b013e3282f3d9ac
   PubMed Web of Science ®Google Scholar
• Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418–426. doi:10.1093/cid/civ312
   PubMed Web of Science ®Google Scholar
• Trent M, Coleman JS, Hardick J, et al. Clinical and sexual risk correlates of Mycoplasma genitalium in urban pregnant and non-pregnant young women: cross-sectional outcomes using the baseline data from the Women’s BioHealth Study. Sex Transm Infect. 2018;94(6):411–413. doi:10.1136/sextrans-2017-053367
   PubMed Web of Science ®Google Scholar
• FDA approves new test for mycoplasma genitalium. Availabe from: https://www.reliasmedia.com/articles/144091-fda-approves-new-test-for-mycoplasma-genitalium?v=preview. Accessed March 26, 2020.
   Google Scholar
• Bradshaw CS, Chen MY, Fairley CK. Persistence of mycoplasma genitalium following azithromycin therapy. PLoS One. 2008;3(11):e3618. doi:10.1371/journal.pone.0003618
   PubMed Web of Science ®Google Scholar
• Conway R, Cook S, Soni SS. Antibiotic treatment of Mycoplasma genitalium infection. Pharm J. 2022;10:283–292.
   Google Scholar
• Butz AM, Gaydos C, Chung SE, Johnson BH, Huettner S, Trent M. Care-seeking behavior after notification among young women with recurrent sexually transmitted infections after pelvic inflammatory disease. Clin Pediatr (Phila). 2016;55(12):1107–1112. doi:10.1177/0009922816662863
   PubMed Web of Science ®Google Scholar
• Nwariaku FE. Performance of medical graduates within and outside Nigeria. Nigerian Medical Journal. 2010;51(2):92.
   Google Scholar
• Adamson PC, Loeffelholz MJ, Klausner JD. Point-of-care testing for sexually transmitted infections a review of recent developments. Arch Pathol Lab Med. 2020;144(11):1344–1351. doi:10.5858/arpa.2020-0118-RA
   PubMed Web of Science ®Google Scholar
• Lee DYJ, Ashcroft MM, Chow EPF, et al. Reflex detection of ciprofloxacin resistance in Neisseria gonorrhoeae by use of the SpeeDx resistancePlus GC assay. J Clin Microbiol. 2021;59(5):e00089–21. doi:10.1128/JCM.00089-21
   PubMed Web of Science ®Google Scholar
• Touati A, Peuchant O, Jensen JS, Bébéar C, Pereyre S. Direct detection of macrolide resistance in mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol. 2014;52(5):1549–1555. doi:10.1128/JCM.03318-13
   PubMed Web of Science ®Google Scholar
• Zheng X, O’Connell CM, Zhong W, et al. Gene expression signatures can aid diagnosis of sexually transmitted infection-induced endometritis in women. Front Cell Infect Microbiol. 2018;8:307. doi:10.3389/fcimb.2018.00307
   PubMed Web of Science ®Google Scholar
• Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis. 2013;26(1):73–79. doi:10.1097/QCO.0b013e32835c21b0
   PubMed Web of Science ®Google Scholar
• Anders J, Hill A, Chung SE, et al. Patient satisfaction and treatment adherence for urban adolescents and young adults with pelvic inflammatory disease. Trauma Emerg Care. 2018;3:1.
   Google Scholar
• Trent M, Perin J, Gaydos CA, et al. Efficacy of a technology-enhanced community health nursing intervention vs. standard of care for female adolescents and young adults with pelvic inflammatory disease: a randomized clinical trial. JAMA Netw Open. 2019;2(8):e198652. doi:10.1001/jamanetworkopen.2019.8652
   PubMed Web of Science ®Google Scholar
• Ha MM, Belcher HME, Butz AM, Perin J, Matson PA, Trent M. Partner notification, treatment, and subsequent condom use after pelvic inflammatory disease: implications for dyadic intervention with Urban Youth. Clin Pediatr (Phila). 2019;58(11–12):1271–1276. doi:10.1177/0009922819852979
   PubMed Web of Science ®Google Scholar
• Trent M, Lehmann H, Butz A, Thompson C, Qian Q, Frick KD. Understanding consumer preferences for care of adolescents with pelvic inflammatory disease. Med Ther Med Reprod Gynecol Endocrinol. 2013;15(4):358–362.
   PubMedGoogle Scholar
• CDC. Infertility & STDs - STD Information from CDC; 2022. Available from: https://www.cdc.gov/std/infertility/default.htm. Accessed April 29, 2022.
   Google Scholar
• Ditkowsky J, Shah KH, Hammerschlag MR, Kohlhoff S, Smith-Norowitz TA. Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States. BMC Infect Dis. 2017;17(1):155. doi:10.1186/s12879-017-2248-5
   PubMedGoogle Scholar
• Poston TB, Gottlieb SL, Darville T. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection. Vaccine. 2019;37(50):7289–7294. doi:10.1016/j.vaccine.2017.01.023
   PubMed Web of Science ®Google Scholar
• Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis. 1996;173(4):950–956. doi:10.1093/infdis/173.4.950
   PubMed Web of Science ®Google Scholar
• Hafner LM, Timms P. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects. Expert Rev Vaccines. 2018;17(1):57–69. doi:10.1080/14760584.2018.1417044
   PubMed Web of Science ®Google Scholar
• De la Maza LM, Zhong G, Brunham RC. Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol. 2017;24(4):e00543–16. doi:10.1128/CVI.00543-16
   PubMed Web of Science ®Google Scholar
• Bøje S, Olsen AW, Erneholm K, et al. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ+ CMI responses protects against a genital infection in minipigs. Immunol Cell Biol. 2016;94(2):185–195. doi:10.1038/icb.2015.79
   PubMed Web of Science ®Google Scholar
• Abraham S, Juel HB, Bang P, et al. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, Phase 1 trial. Lancet Infect Dis. 2019;19(10):1091–1100. doi:10.1016/S1473-3099(19)30279-8
   PubMed Web of Science ®Google Scholar
• Gottlieb SL, Jerse AE, Delany-Moretlwe S, et al. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap. Sex Health. 2019;16(5):426–432. doi:10.1071/SH19060
   PubMed Web of Science ®Google Scholar
• Ali S, Ali S, Javed SO, et al. Proteome wide vaccine targets prioritization and designing of antigenic vaccine candidate to trigger the host immune response against the Mycoplasma genitalium infection. Microb Pathog. 2021;152:104771. doi:10.1016/j.micpath.2021.104771
   PubMed Web of Science ®Google Scholar
• Wei A, Feng H, Jia XM, Tang H, Liao YY, Li BR. Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease. Biomed Pharmacother. 2018;107:1418–1425. doi:10.1016/j.biopha.2018.07.137
   PubMed Web of Science ®Google Scholar